Physician profile
Iris Javersak
NPI 1417508151
$1,535.96
in general payments reported to CMS, 2019-2025
9 companies · $398 in 2025
The $398 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $180 · 2022: $414 · 2023: $333 · 2024: $211 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $942.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $941.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $891.09 | 2021-2025 | Mazor X System, Catalyft Pl Expandable Interbody System, Magnifuse Bone Graft |
| Cerapedics INC. | $425.38 | 2022-2025 | I-Factor Peptide Enhanced Bone Graft |
| Orthofix Medical, INC. | $91.75 | 2021-2023 | Spinal-Stim, Spinal-Stim |
| Ucb, INC. | $30.50 | 2021 | |
| Stryker Corporation | $21.76 | 2025 | Adherus Autospray Dural Sealant |
| Takeda Pharmaceuticals U.S.A., INC. | $21.49 | 2025 | Hyqvia |
| Supernus Pharmaceuticals, INC. | $19.81 | 2022 | |
| Neurocrine Biosciences, INC. | $18.84 | 2025 | |
| Lundbeck LLC | $15.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Iris Javersak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.